News and Media



Press Releases

Cetaphil® Expands Skincare Portfolio to Include Seven New Facial Care Products in 2017
An Extension of Their Award-Winning Line of Cleansers and Moisturizers

Galderma Announces Skincare Collaboration with Colorescience®
New joint promotion improves access to variety of daily skincare and injectable facial aesthetic treatments across the U.S.

Modernizing Medicine and Galderma Announce Integrated Over-the-Counter eCommerce Platform
New Capabilities Streamline Patient Treatment Plans and Simplify Patient Purchasing

Differin® Gel Acne Treatment Partners with Actress Ashley Benson to End Adult Acne Frustrations for Millions of Sufferers
First-Ever Over the Counter (OTC) Retinoid Acne Treatment Now Available Nationwide

Galderma Announces FDA Approval of Restylane® Refyne and Restylane® Defyne Dermal Fillers for Treatment of "Laugh Lines"
Next-generation flexible hyaluronic acid dermal fillers provide natural-looking results through XpresHAn Technology

Galderma to Share Data from Phase 3 Studies of New Investigational Restylane® Refyne and Restylane® Defyne at American Society for Dermatologic Surgery Annual Meeting
Pivotal phase 3 data highlights efficacy and safety in anticipation of U.S. Food and Drug Administration (FDA) review and global post-market analysis reports on safety data collected from more than 2,000 patients

Leadership change at Nestlé Skin Health

Fort Worth-Based Galderma Stuffs the Bus with 1,250 Backpacks Full of School Supplies for Northwest ISD Students

Chugai and Galderma Announce Global License Agreement for Nemolizumab (CIM331), Novel Biologic for Skin Diseases

Galderma Announces FDA Approval of Full Prescription-Strength Differin® Gel For Over-the-Counter Acne Use
First new active ingredient approved to treat acne without a prescription in over 30 years

Galderma’s Cetaphil® Launches Limited-edition Product Display Honoring Camp Wonder
Seen exclusively at CVS Pharmacy locations nationwide

Galderma Invites Teens to Take a Two-Week Challenge with Benzac to Get Control of Acne Breakouts and Help Prevent Them from Coming Back
Enter Benzac’s Instagram Sweepstakes for a Chance to Get Clearer Skin and Win a Summer Prize Pack

Galderma Celebrates 20th Global Anniversary of Restylane®
Restylane® Marks Heritage Milestone and Announces Innovative Syringe

GALDERMA ANNOUNCES POSITIVE RESULTS FROM THE COMPLETE REGIMEN STUDY INCLUDING EPIDUO® GEL IN THE MANAGEMENT OF ACNE IN ADOLESCENT STUDENT ATHLETES
Young athletes need take extra precaution to safe guard their skin health, as 8 out of 10 of pre-teen and adolescent teens will encounter some form of acne as a natural side effect of puberty

Galderma Laboratories Announces Availability of New Mirvaso® (brimonidine) Topical Gel, 0.33%* Pump Dispenser for the Treatment of the Persistent Facial Redness of Rosacea
New Pump Delivery System Dispenses a Consistent Dose at Each Use

Galderma, Global Leader in Skin Health, Expands its Fort Worth Footprint
Expansion adds 100,000-square-feet and up to 350 Employees to Fort Worth Headquarters in the next few years

GALDERMA SKIN CARE LINE EXCIPIALTM PARTNERS WITH THE AMERICAN CULINARY FEDERATION TO HELP PROTECT AND REPAIR CHEFS’ HANDS
FORT WORTH, Texas, May 2, 2016 - Galderma Laboratories, L.P., maker of Excipial, has teamed up with the American Culinary Federation (ACF), the nation’s premier organization for professional chefs and cooks, to share with chefs a new solution for treating dry hands.

NATIONAL SURVEY REVEALS REACTIVE ACNE TREATMENT PERSISTS, DESPITE EMOTIONAL STRUGGLE ASSOCIATED WITH BREAKOUTS
Galderma Laboratories, L.P. announces results of survey of teens and young adults who have experienced acne

It’s Time to Face the Facts: New Data Suggests Rosacea Is More Than Just Skin Deep
Galderma Laboratories, L.P. and the National Rosacea Society Launch Campaign/Contest to Educate Public on Rosacea and Help Sufferers Feel More Confident in their Skin

Galderma Unveils the New Cetaphil® Brand Graphics & Packaging
Updates Aim to Improve In-Store Shopper Experience

GALDERMA URGES WOMEN AND MEN TO BREAK THE ICE ON A CONVERSATION ABOUT TREATING FROWN LINES AND FEAR OF THE FROZEN LOOK

Galderma Announces U.S. Collaboration in Aesthetics with Mentor Worldwide, LLC

Galderma Laboratories Announces the National Launch of qilibTM, a Breakthrough, New Hair Care Line Created to Regrow, Revitalize and Improve Hair Health
qilib Offers Men and Women Effective Solutions with Clinically Proven Minoxidil and Natural Botanical Ingredients

NestlÉ Skin Health Appoints Dr. Johannes J. Baensch as Chief Scientific Officer

GALDERMA UNVEILS NEW DIRECT-TO-CONSUMER CREATIVE CAMPAIGNS FEATURING REAL WOMEN, REAL RESULTS
Campaigns Empower Women to Embrace Their Desire to Look Their Best with Products that Provide Natural-Looking Results

GALDERMA DELIVERS INNOVATION IN DERMAL FILLERS WITH THE LAUNCH OF TWO FIRST-IN-CLASS FDA PIVOTAL PHASE III TRIALS

The Cetaphil® Brand Introduces Its Newest Product Line, New Cetaphil® Men
Gentle Power of Cetaphil is now available for men

NEW GALDERMA CAMPAIGN ENCOURAGES WOMEN TO LOVE THEIR MOM GENES

Galderma Laboratories, L.P. Appoints Miles Harrison as Leader of U.S. and Canada

Cetaphil® Announces the Cetaphil® Baby Babymoon Sweepstakes
New & Expectant Parents Can Enter for a Chance to Win a Trip to Miami Beach!

Galderma Receives FDA Approval for New Antibiotic-Free Treatment Option for Acne Patients
FDA Approval of Epiduo® Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% Further Expands Galderma’s Portfolio of Dermatologic Solutions

Galderma SKIN PACT Awards recognize four original dermatology projects that aim to generate a positive impact in advancing sustainable innovation through Community Leadership and Continuing Education

Galderma Laboratories, L.P. is Participating in the White House Forum on Antibiotic Stewardship
- Appropriate Use of Antibiotics in Dermatology Gains National Attention

NATIONAL SURVEY REVEALS THAT ROSACEA SUFFERERS OFTEN HIDE BEHIND COSMETICS BEFORE TREATING THE CONDITION
- Galderma Laboratories, L.P. and The National Rosacea Society Launch Break Up with Your Makeup to Clarify Common Rosacea Misconceptions and Empower Those Impacted to Take Action

Introducing ASPIRE Galderma Rewards, the Aesthetic Industry’s Premier New Loyalty Program
- New rewards-based program demonstrates Galderma’s commitment to aesthetics market with industry-leading benefits for healthcare providers and consumers

Cetaphil® Baby Expands Distribution Into Select Retailers
- Now Available at Walmart & Buy Buy Baby

Galderma Announces Two New Senior Leadership Positions
- VP/GM of New Aesthetic & Corrective Business Unit;
  Senior Director of Organizational Health

Benzac® Acne Solutions Premieres Its First-Ever Insta-Dramedy Webseries
- The Benzacs Debuts on Instagram to Entertain & Encourage Teens to Ditch the Acne Drama

GALDERMA ANNOUNCES POSITIVE PHASE 3 TRIAL RESULTS OF INVESTIGATIONAL ADAPALENE 0.3%/BENZOYL PEROXIDE 2.5% (0.3% A/BPO) FOR THE TREATMENT OF ACNE
- Pivotal Data Presented at This Year’s American Academy of Dermatology Meeting

GALDERMA POISED FOR GROWTH IN THE U.S. WITH HOLISITC APPROACH TO SKIN HEALTH
- Broad range of solutions and strong pipeline of science-based products uniquely position Galderma as world leader in skin health

NestlÉ SKIN HEALTH ANNOUNCES LEADERSHIP TEAM
- Nestlé Skin Health announces organizational changes at top management level to support the company’s expanded market opportunity and ambition

Galderma Announces Availability of Soolantra® (ivermectin) Cream, 1%
- Newly Approved Prescription Treatment Option Now Available for Rosacea Patients in Pharmacies Nationwide

GALDERMA LABORATORIES LAUNCHES ITS FIRST OVER-THE COUNTER ACNE REGIMEN, BENZAC® ACNE SOLUTIONS
- Benzac Fights Acne by Combining Proven Acne Fighting Medicine with Breakthrough Natural Ingredients

Galderma Receives FDA Approval of Novel Treatment Option for Rosacea Patients
- Soolantra® (ivermectin) Cream, 1% found to be well tolerated with powerful results seen as early as two weeks

NestlÉ Skin Health to Open Global Network of Innovation Hubs to Advance Next Generation of Skin Health

The Cetaphil® Brand Launches New Cetaphil® Baby Line
- The Gentle Power of Cetaphil is now available for baby

RESPONSIBLE USE OF ANTIBIOTICS IN DERMATOLOGY SUPPORTED DURING CDC’S GET SMART ABOUT ANTIBIOTICS WEEK
- Galderma Laboratories, L.P. and American Acne and Rosacea Society Become First Dermatology Organizations to Join the Effort

The Cetaphil® Brand Revamps RestoraDerm® Product Line
- Same eczema soothing power, with a new look

Galderma Initiates U.S. Study of Novel Muscle Relaxant for Aesthetic Dermatology and Cosmetic Surgery

THE CETAPHIL® BRAND UNVEILS NEW LIMITED EDITION PACKAGING FOR CAMP WONDER
- Benefitting the Children’s Skin Disease Foundation

Galderma Finalizes Major Expansion in Aesthetic and Corrective Dermatology in the U.S. and Canada
- Expansion Completes Galderma’s Global Skin Health Footprint

Galderma Unites with Hit Music Artists and PACER’S National Bullying Prevention Center to Raise the Volume around Bullying Prevention
- Band Together to Banish Bullying (#BTProject) Launches to Activate Conversation and Create Hope for the 1 in 3 Students Impacted by Bullying

Galderma to gain rights to Restylane, Perlane, Sculptra and Dysport in the United States and Canada
- Galderma positioned to commercialize Restylane®, Perlane®, Emervel®, Sculptra®, Dysport® in the U.S. and Canada
- Galderma reinforces long-term commitment to meet physician and patient needs in aesthetic and corrective dermatology worldwide

Galderma CETAPHIL BRAND UNVEILS FIRST FULLY INTEGRATED CAMPAIGN: GENTLE POWER

Galderma Announces Positive Results of Phase 3 Trials of Investigational Ivermectin 1% Targeting Papulopustular Rosacea
- Efficacy and Safety Data Presented at Late-Breaking Session of American Academy of Dermatology Meeting

Galderma RED IS WRONG: Galderma Kicks Off Direct to Consumer Symptom Awareness Campaign
- Right the Wrong of Rosacea with Awareness, Education and Treatment

NestlÉ Skin Health Is Created Targeting Global Skin Health Needs

Galderma Announces the Publication of Positive Results of the Long-Term Study of Mirvaso® Gel for Treatment of Persistent Erythema of Rosacea
- Efficacy and Safety Results from One-Year Study Published in Journal of Drugs in Dermatology

GALDERMA’S GLOBAL LEADER HONORED WITH A LIFETIME IN DERMATOLOGY ACHIEVEMENT AWARD BY JOURNAL OF DRUGS IN DERMATOLOGY

GALDERMA ANNOUNCES CEO FOR NORTH AMERICAN OPERATIONS

Galderma Serves as Premier Sponsor for 2013 Commit to Cure Gala Benefitting National Psoriasis Foundation
- Baylor Medical Center dermatologist Alan Menter, M.D., honored with Lifetime Achievement Award for psoriasis research and patient care.

The Cetaphil® Brand Unveils New Limited‐Edition Packaging for Camp Wonder
- To give children with serious skin diseases the chance to be kids.

Jeannette R. Jakus, MD, MBA, Awarded American Academy of Dermatology Translational Biotechnology Fellowship at Galderma

Galderma Receives FDA Approval of Mirvaso®: the First and Only FDA-Approved Topical Treatment Specifically Developed and Indicated for the Facial Erythema of Rosacea
- Mirvaso Works Quickly and Lasts up to 12 Hours.

Epiduo® Gel and Pacer's National Bullying Prevention Center Partner on the Banish Bullying Campaign
- 77 percent of students have admitted to experiencing some kind of bullying-- --One out of every four kids will be bullied sometime throughout their adolescence.

The American Academy of Dermatology and Galderma Announce New, Innovative Research Fellowship
- The new fellowship offers a dermatologist the opportunity to work in drug development and translational medical research at Galderma's R&D facility located in Sophia Antipolis, France.

Epiduo® Gel Becomes First Topical Prescription Acne Treatment Available for Children as Young as 9 Years-Old
- FDA-Approval Provides Pediatricians and Dermatologists with Safe and Effective Treatment for Younger Children Suffering from Acne

Epiduo® Tap Program May Increase Patient Adherence to Acne Treatment
- Multi-Media Program Provides Epiduo® Gel Patients with Tools to Track Treatment.

Nuvo Research Announced U.S. Launch of Pliaglis® by Galderma
- Pliaglis® is indicated for use on intact skin in adults to provide local analgesia for superficial aesthetic procedures.

Galderma's Tri-Luma Cream®, Only FDA-Approved Treatment for Melasma, Now Available in Pharmacies
- Clinically Proven Treatment Can Help More than 7 Million Suffering from Melasma in the U.S.

Nuvo and Galderma Announce FDA Approval of Pliaglis®
- Pliaglis Offers a Pre-Treatment Topical Solution and Contributes to Improving the Patient Experience of Aesthetic Procedures

The Cetaphil® Brand Teams with Camp Wonder
- To Give Children With Serious Skin Diseases the Chance to Be Kids

Fort Worth-Based Galderma Laboratories Pledges Additional $450, 000 for Dermatology Program
- A Residency Program At Baylor Dallas To Educate the Next Generation of Dermatologists in North Texas

Actress Cynthia Nixon Reveals How Rosacea Has Impacted Her Life
- New Public Service Announcement Encourages Awareness and Diagnosis of Common Skin Condition During Rosacea Awareness Month in April

Galderma Announces Completion of Phase 3 Trials of Investigational Drug Targeting Facial Erythema of Rosacea
- Phase 3 Trials Confirm Findings of Phase 2 Studies

Cetaphil® Brand Launches Cetaphil®; DermaControlTM A New Line of Products for Acne-prone Skin
- Introducing Cetaphil® DermaControlTMFoam Wash and Moisturizer SPF30, Specially Designed for Patients with Acne-Prone Skin

Galderma Receives FDA Approval for New Convenient Pump Dispenser of Differin® Gel, 0.3% For Treatment of Acne Vulgaris
- Acne Sufferers Prefer Pump Over Tube Delivery, Patient Preference Survey Shows

Galderma Announces Availability of New MetroGel® 1% Pump Dispenser for the Treatment of Papulopustular Rosacea
- Pump Delivery Provides Consistent Dosing, Minimizes Waste and May Help Increase Patient Compliance

#1 Branded Topical Acne Product, Epiduo® Gel, Receives FDA for A New Convenient Pump Dispenser
- Study Shows that Acne Sufferers Prefer Pump Delivery for Treatment Administration

© 2013-2016 Galderma Laboratories, L.P. United States, All trademarks are the property of their respective owners. All Rights Reserved. This site intended for U.S. audiences only.

Custom Photography by: © Stewart Cohen Pictures and TOM HUSSEY Photography, LLC

Corporate site | Privacy | Legal | Compliance Program | Site Map